Thursday, July 05, 2007

GSK - Avandia: "first do no harm"

The jury may still be out with regard to the cardiotoxicity of rosiglitazone, but when it comes to patient safety, "first, do no harm" should outweigh any presumption of innocence.

David M Nathan MD - NEJM

No comments: